How the Kiplinger 25 Are Handling the Market Turbulence
Some of our favorites have taken a beating over the past couple of weeks. Others are little affected.
These are testing times for fund managers. From a market high on July 19, Standard & Poor's 500-stock index had slumped 7.3% (including dividends) by the close on August 3. Volatility spiked. The small-company Russell 2000 index surrendered nearly 11% during the same time span. How fared the stock funds in the Kiplinger 25?
The results were mixed. It's little surprise that Merger (MERFX), which doesn't correlate closely to stock market performance, held its value best, shedding less than 2% during the turbulent 15-day timeframe. Next best was Ken Heebner's CGM Focus (CGMFX), which fell less than 3% and was up a staggering 29% year to date. Heebner dumped his investment-bank stocks before the group started to roll over in late spring and, if his March 31 portfolio is anything to go by, is benefiting from a large position in foreign and energy and industrial-material stocks.
Bill Miller's Legg Mason Opportunity Primary (LMOPX) was enjoying an outstanding year until the market plunge clocked his fund more than 11%. But at least Miller's fund has still returned 5% for the year, three percentage points ahead of the S&P index.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Muhlenkamp (MUHLX) and Bill Nygren's Oakmark Select (OAKLX), both value-oriented funds, fell more than 10% during the commotion and have lost money for investors this year. Ill-timed holdings in homebuilders and thrifts -- both have large investments in Washington Mutual -- tarred both funds. Ron Muhlenkamp must wonder what he was thinking when he made Countrywide Financial, a leading mortgage lender, a top-five position in his portfolio. Countrywide has plummeted 41% this year and homebuilder Toll Brothers, another large Muhlenkamp position, lost a third of its value.
T. Rowe Price Growth Stock (PRGFX) and Vanguard Primecap Core (VPCCX) held up relatively well and have handily beaten the S&P index this year: large-company growth appears to be besting value in general this year. Growth Stock has shown some adroit stock selection this year, with large positions in Schlumberger, CVS Caremark and Accenture, all big gainers.
In the small-company camp, Champlain Small Company Advisor (CIPSX) continues to shine. It fell 5%, less than half the Russell 2000 decline, and was up 7% for the year, beating the index by an impressive 11 percentage points.
(Visit the Kiplinger 25 Center to learn more about our favorite funds.)
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Andrew Tanzer is an editorial consultant and investment writer. After working as a journalist for 25 years at magazines that included Forbes and Kiplinger’s Personal Finance, he served as a senior research analyst and investment writer at a leading New York-based financial advisor. Andrew currently writes for several large hedge and mutual funds, private wealth advisors, and a major bank. He earned a BA in East Asian Studies from Wesleyan University, an MS in Journalism from the Columbia Graduate School of Journalism, and holds both CFA and CFP® designations.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
The Kiplinger 25: Our Favorite No-Load Mutual Funds
The Kiplinger 25 The Kiplinger 25 is a list of our top no-load mutual funds that have proven capable of weathering any storm.
By Nellie S. Huang Last updated
-
The 5 Best Actively Managed Fidelity Funds to Buy Now
mutual funds In a stock picker's market, it's sometimes best to leave the driving to the pros. These Fidelity funds provide investors solid active management at low costs.
By Kent Thune Last updated
-
The 12 Best Bear Market ETFs to Buy Now
ETFs Investors who are fearful about the more uncertainty in the new year can find plenty of protection among these bear market ETFs.
By Kyle Woodley Published
-
Don't Give Up on the Eurozone
mutual funds As Europe’s economy (and stock markets) wobble, Janus Henderson European Focus Fund (HFETX) keeps its footing with a focus on large Europe-based multinationals.
By Rivan V. Stinson Published
-
Best Bond Funds to Buy
Investing for Income The best bond funds provide investors with income and stability – and are worthy additions to any well-balanced portfolio.
By Jeff Reeves Last updated
-
Vanguard Global ESG Select Stock Profits from ESG Leaders
mutual funds Vanguard Global ESG Select Stock (VEIGX) favors firms with high standards for their businesses.
By Rivan V. Stinson Published
-
Kip ETF 20: What's In, What's Out and Why
Kip ETF 20 The broad market has taken a major hit so far in 2022, sparking some tactical changes to Kiplinger's lineup of the best low-cost ETFs.
By Nellie S. Huang Published
-
ETFs Are Now Mainstream. Here's Why They're So Appealing.
Investing for Income ETFs offer investors broad diversification to their portfolios and at low costs to boot.
By Nellie S. Huang Published